Orion Infusion Limited

DSE:ORIONINFU Stock Report

Market Cap: ৳12.9b

Orion Infusion Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Salman Karim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure10.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure24.3yrs

Recent management updates

Recent updates


CEO

Salman Karim (42 yo)

10.3yrs

Tenure

Mr. Salman Obaidul Karim is the Managing Director at Orion Group since January 2020. He served as the Chief Executive Officer, Managing Director and Executive Director of Orion Pharma Limited since Septemb...


Board Members

NamePositionTenureCompensationOwnership
Salman Karim
MD, CEO & Director24.3yrsno datano data
Md. Rahman
Independent Director6.3yrs৳120.00kno data
Mohammad Karim
Chairman37.3yrs৳50.00k3.24%
BDT 417.9m
Arzuda Karim
Non-Executive Director37.3yrs৳120.00k5.79%
BDT 748.2m
Zareen Karim
Non-Executive Director24.3yrs৳120.00k9.82%
BDT 1.3b

24.3yrs

Average Tenure

68yo

Average Age

Experienced Board: ORIONINFU's board of directors are seasoned and experienced ( 24.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.